Also trades as: CAN.AX (ASX) · $vol 0M
CNGGF OTC
Cann Group Limited
1W: +41.2%
1M: -16.9%
3M: -16.9%
YTD: -53.3%
1Y: -43.5%
3Y: -96.5%
5Y: -98.7%
$0.00
-0.00 (-20.42%)
Weekly Expected Move ±28.8%
$0
$0
$0
$0
$0
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
No convergence signal
Key Statistics
Market Cap$4.7M
52W Range0.0015-0.02
Volume3,600
Avg Volume4,193
Beta0.11
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJennifer Lee Pilcher
Employees98
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2021-01-08
Websitecanngrouplimited.com
23 Greentek Court
Mildura, VIC 3501
AU
Mildura, VIC 3501
AU
61 3 9095 7088
About Cann Group Limited
Cann Group Limited specializes in the end-to-end process of bringing medicinal cannabis to market. Its activities span from genetic development and cultivation to product manufacturing, clinical trials, and ultimately, the supply of therapeutic cannabis for both Australian consumption and international export. The company holds specific licenses enabling it to conduct research and grow cannabis for human medicinal and scientific study. Founded in 2014, Cann Group Limited operates out of its base in Port Melbourne, Australia.
Latest News
No recent news
Recent Insider Trades
No insider trades found